v3.23.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Schedule of financial liabilities measured at fair value on recurring basis
The following tables provide a summary of the liabilities measured at fair value on a recurring basis (in thousands): 
 June 30, 2023
(Level 1)(Level 2)(Level 3)Total
 Balance
Embedded derivative within 2023 Funding Agreement$— $— $(42)$(42)
Total liabilities measured at fair value$— $— $(42)$(42)

 December 31, 2022
(Level 1)(Level 2)(Level 3)Total
 Balance
Compound embedded derivative within the 2019 Facility Agreement— — (122)(122)
Total liabilities measured at fair value$— $— $(122)$(122)
Schedule of rollforward of assets and liabilities measured at fair value
The following table presents a rollforward for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in thousands):
Six Months Ended 
June 30, 2023
Twelve Months Ended December 31, 2022
Balance at beginning of period, January 1, 2023 and 2022, respectively$(122)$(880)
Issuance of embedded derivative within the 2023 Funding Agreement(341)— 
Derivative adjustment related to conversions— 1,563 
Derivative adjustment related to extinguishment of debt122 — 
Unrealized gain (loss), included in derivative gain (loss)299 (805)
Balance at end of period, June 30, 2023 and December 31, 2022, respectively
$(42)$(122)